Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Hood

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
BMC Genomics|December 31, 2024
Nanopore sequencing as a novel method of characterising anorexia nervosa risk lociNatasha Berthold, Silvana Gaudieri, Sean Hood, et al.
International Journal of Public Health|September 21, 2023
Mental Health Status, Risk and Protective Factors for Healthcare Staff Prior to the First Major COVID-19 Outbreak in Western AustraliaElizabeth A Newnham, Enrique L P Mergelsberg, Jessica Tearne, et al.
Bjpsych Open|December 5, 2024
A longitudinal study of healthcare workers' mental health during Western Australia's unique policy response to COVID-19Elizabeth A Newnham, Enrique L P Mergelsberg, Susanne Stanley, et al.
JAMA Network Open|May 20, 2026
Mapping Aboriginal Mental Health Journeys Through Psychiatric Care SystemsHelen Milroy, Blerida Banushi, Beatriz Cuesta Briand, et al.
Journal of Synchrotron Radiation|September 3, 2021
Towards high spatial resolution tissue-equivalent dosimetry for microbeam radiation therapy using organic semiconductorsJessie A Posar, Matthew Large, Saree Alnaghy, et al.
Journal of Affective Disorders|February 20, 2024
Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)Donel M Martin, Anna J Harvey, Bernard Baune, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|May 9, 2026
Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS)Gregory Carter, Maree Hackett, Stevan Nikolin, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigmDaniel Perkins, Jerome Sarris, Susan Rossell, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
BMC Genomics|December 31, 2024
Nanopore sequencing as a novel method of characterising anorexia nervosa risk lociNatasha Berthold, Silvana Gaudieri, Sean Hood, et al.
International Journal of Public Health|September 21, 2023
Mental Health Status, Risk and Protective Factors for Healthcare Staff Prior to the First Major COVID-19 Outbreak in Western AustraliaElizabeth A Newnham, Enrique L P Mergelsberg, Jessica Tearne, et al.
Bjpsych Open|December 5, 2024
A longitudinal study of healthcare workers' mental health during Western Australia's unique policy response to COVID-19Elizabeth A Newnham, Enrique L P Mergelsberg, Susanne Stanley, et al.
JAMA Network Open|May 20, 2026
Mapping Aboriginal Mental Health Journeys Through Psychiatric Care SystemsHelen Milroy, Blerida Banushi, Beatriz Cuesta Briand, et al.
Journal of Synchrotron Radiation|September 3, 2021
Towards high spatial resolution tissue-equivalent dosimetry for microbeam radiation therapy using organic semiconductorsJessie A Posar, Matthew Large, Saree Alnaghy, et al.
Journal of Affective Disorders|February 20, 2024
Cognitive outcomes from the randomised, active-controlled Ketamine for Adult Depression Study (KADS)Donel M Martin, Anna J Harvey, Bernard Baune, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|May 9, 2026
Suicidal Ideation Effectiveness and Safety Outcomes from the Ketamine for Adult Depression Study (KADS)Gregory Carter, Maree Hackett, Stevan Nikolin, et al.
The Australian and New Zealand Journal of Psychiatry|March 22, 2021
Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigmDaniel Perkins, Jerome Sarris, Susan Rossell, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 7, 2025
Effect of ketamine on anxiety: findings from the Ketamine for Adult Depression StudyNatalie T Mills, Stevan Nikolin, Nick Glozier, et al.
Journal of Affective Disorders|May 29, 2025
Economic evaluation of subcutaneous ketamine injections for treatment resistant depression: A randomised, double-blind, active-controlled trial - The KADS studyMary Lou Chatterton, Johana Kevin Perez, Thao Thai, et al.
Pageof 4